Gone are the days of outsourcing the production of aseptic products based only on the cost per unit. With manufacturers entering into consent decrees and closing key facilities, pharma companies are looking for contract manufacturing organizations (CMOs) with more robust product delivery systems that adhere to current good manufacturing practices (cGMPs), have validatable cleaning and decontaminations methods, and comply with global regulatory requirements.

To read more go to https://www.contractpharma.com/issues/1013/view_Back-page/the-next-generation-cmos/